News! Read PR
$Brainstorm Cell Therapeutics (BCLI.US)$ BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn in ALS
PR Newswire· 2 mins ago
PR Newswire· 2 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MikeyMikeMike : 100-1 Call/Put ratio. Alot of people are betting this will go up. But I don't know how to play options yet, jut look at them to see which way people are betting.
Trytosaveabit OP MikeyMikeMike : Absolutely! If shorts stay off it, I expect a good day! GL
Quah : is it good?
Trytosaveabit OP Quah : I’ll let you decide? I like it! Our meeting with the FDA provided us with valuable input on the Phase 3b trial design, outlining clear steps forward," said Chaim Lebovits, President and Chief Executive Officer of BrainStorm. "We believe that a SPA will serve to help de-risk certain regulatory aspects of the NurOwn clinical program. We recognize the urgency in providing ALS patients with safe and efficacious treatments and are committed to agreeing on a regulatory path forward for NurOwn. We are grateful for the FDA's continued support and guidance and look forward to providing further updates once we have more clarity on an SPA." GL
MikeyMikeMike Quah : yes. as long as Short stay out or enough volume to squeeze. If squeeze happen, could make outcome even better. Not financial advice. Your money, your misery
MikeyMikeMike : Got short stats on this @Alvinnnnnnn89 @Charles Wellington
Quah Trytosaveabit OP : thanks!
Trytosaveabit OP Quah : Sorry was checking Coyote traps and just got back! You’re very welcome! It got a decent pop! I sold part of my position and now looking for bottom to buy more for a swing trade! I like this as a future runner and that’s why I took some profit again but will now start accumulating! GL my friend